MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Association between transfer activities and health-related quality of life in patients with Parkinson’s disease

    AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)

    Objective: To investigate the association between health-related quality of life (HRQoL) and transfer activities in patients with Parkinson's disease (PD). Background: Bradykinesia, rigidity, tremor and…
  • 2019 International Congress

    Motor Response Inhibition – A potential tool to determine optimum STN-DBS setting

    H. Kumar, A. Roy, S. Choudhury, P. Basu, M. Baker, S. Baker (Kolkata, India)

    Objective: To explore the possibility of using an automated bed side test of motor response inhibition - Stop Signal Reaction Time (SSRT) while optimizing DBS…
  • 2019 International Congress

    The effects of obstacle size and timing on prefrontal cortex activation in patients with Parkinson’s disease

    I. Maidan, T. Sharon, I. Kurz, H. Bernad-Elazari, S. Shustak, I. Galperin, N. Giladi, A. Mirelman, J. Hausdorff (Tel Aviv, Israel)

    Objective: To evaluate the effects of obstacle height and anticipation time on prefrontal cortex (PFC) activation in patients with Parkinson's disease (PD) and older adults.…
  • 2019 International Congress

    Parkinson Disease Clinical Subtypes Predict Dementia and Mortality Risk

    P. Myers, M. Campbell, A. Weigand, N. Cairns, J. Jackson, C. Lessov-Schlaggar, J. Perlmutter (St. Louis, MO, USA)

    Objective: To identify PD clinical subtypes based on patterns of motor, cognitive, and psychiatric symptoms; to assess the clinical utility of each subtype in predicting…
  • 2019 International Congress

    Diplopia and visual complaints in non-demented patients with Parkinson disease: a Japanese single center cross-sectional survey

    K. Ota, K. Takahashi, K. Seo, H. Kawasaki, K. Ikeda, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Tamura, N. Araki, T. Yamamoto (Saitama-Ken, Japan)

    Objective: To investigate the characterization of diplopia and visual complaints including minor forms of hallucinations (mHals) in non-demented patients with Parkinson disease (PD). Background: Double…
  • 2019 International Congress

    Acute Onset Parkinsonism Secondary to West Nile Virus Encephalitis

    M. Purbaugh, F. Ali, T. Diesing, A. Hellman (Omaha, NE, USA)

    Objective: To demonstrate a case of acute Parkinsonism caused by West Nile Virus (WNV) Encephalitis that improved with resolution of the infection. Background: Acute onset…
  • 2019 International Congress

    An atypical and interesting feature of Parkinson´s disease

    B. Santos, M. Spitz (Rio de Janeiro, Brazil)

    Objective: To describe the symptoms of three PD patients who exhibited marked facial asymmetry. We also briefly review the literature regarding hemihypomimia in PD and…
  • 2019 International Congress

    REM sleep behavior disorder and REM sleep without atonia is a progression marker in Parkinson’s disease: a report from the DeNoPa cohort

    F. Sixel-Döring, L. Zimansky, ML. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

    Objective: To investigate the development of REM sleep behavior disorder (RBD) and REM sleep without atonia (RWA) in Parkinson’s disease (PD) patients from the de…
  • 2019 International Congress

    Identification of potential new genes involved in autosomal recessive forms of Parkinson’s disease

    C. Tesson, A. Honoré, V. Drouet, H. Bertrand, S. Lesage, A. Brice (Paris, France)

    Objective: The aim of the work is to identify new genes involved in autosomal recessive (AR) early-onset (EO, >40 years) Parkinson disease (PD), using consanguineous…
  • 2019 International Congress

    Hoover’s Sign in Parkinson’s Disease

    A. Vasilenko, M. Karpova (Chelyabinsk, Russian Federation)

    Objective: To study applicability of Hoover's sign to diagnostics of functional component in PD. Background: It has been reported that Parkinson’s Disease (PD) patients have…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • #24752 (not found)
    • Effect of Aspartame on Parkinson’s Disease Progression and Severity
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley